Treatment plan for newly diagnosed pediatric patients with advanced stage lymphoblastic NHL and T-cell all at the national caner institute /
Ossama Mohamed Mohamed Maher
Treatment plan for newly diagnosed pediatric patients with advanced stage lymphoblastic NHL and T-cell all at the national caner institute / خطة علاج الحالات الجديدة للمرحلة المتقدمة من الليمفوما الليمفوبلاستية وسرطان الدم الحاد الليمفاوى من نوع الخلايا (تاء) للأطفال بالمعهد القومى للأورام Ossama Mohamed Mohamed Maher ; Supervised Mohamed Hani M. Hussein , Alaa Elhadad , Heba Sayed Moussa - Cairo : Ossama Mohamed Mohamed Maher , 2009 - 282P. : charts ; 25cm
Thesis (Ph.D.) - Cairo University - National Cancer Institute - Department of Pediatric Oncology
Although lymphoid malignancies with T- cell immunophenotype are associated with distinictive clinical and biologic features , true lineage specific treatment has not been identified.Recent trials showed excellent outcomes for patients with advaced T-cell malignancies.Treatment included rotating combinations of myelosuppressive agents proved to be effective in pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma
Advanced stage lymphoblastic HDMTX T-cell acute lymphoblastic leukemia
Treatment plan for newly diagnosed pediatric patients with advanced stage lymphoblastic NHL and T-cell all at the national caner institute / خطة علاج الحالات الجديدة للمرحلة المتقدمة من الليمفوما الليمفوبلاستية وسرطان الدم الحاد الليمفاوى من نوع الخلايا (تاء) للأطفال بالمعهد القومى للأورام Ossama Mohamed Mohamed Maher ; Supervised Mohamed Hani M. Hussein , Alaa Elhadad , Heba Sayed Moussa - Cairo : Ossama Mohamed Mohamed Maher , 2009 - 282P. : charts ; 25cm
Thesis (Ph.D.) - Cairo University - National Cancer Institute - Department of Pediatric Oncology
Although lymphoid malignancies with T- cell immunophenotype are associated with distinictive clinical and biologic features , true lineage specific treatment has not been identified.Recent trials showed excellent outcomes for patients with advaced T-cell malignancies.Treatment included rotating combinations of myelosuppressive agents proved to be effective in pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma
Advanced stage lymphoblastic HDMTX T-cell acute lymphoblastic leukemia